The Patient-Centered Outcomes Research Institute (PCORI) has awarded the Cleveland Clinic $6.7 million to identify optimal treatment strategies for people with relapsing-remitting multiple sclerosis (RRMS). The funds will support the extension study of the multicenter DELIVER-MS (NCT03535298) clinical trial. The study is comparing two MS treatment approaches…
Read more
Intimacy and sexuality among people with multiple sclerosis (MS) will be the focus of this year’s Holistic Health and Wellness Forum for MS, presented by Yoga Moves MS — a U.S. program aiming to improve quality of life for those with neuromuscular conditions — on May 21 in Michigan…
Well, it’s that time of year again, and I’m not referring to allergy season or baseball. It’s time for my MRI to evaluate my multiple sclerosis (MS). For the last three years, I was getting an MRI every 18 months. But at my last visit I saw a…
Early treatment with Ocrevus (ocrelizumab) may help protect the cerebellum, a region of the brain that plays a key role in motor coordination, cognitive function, and emotional regulation, from damage in people with multiple sclerosis (MS), a study suggested. Data from the clinical studies that supported Ocrevus’ approval…
New diagnostic criteria and biomarkers, how to manage MS in older patients and children, and vaccine recommendations are among topics covered in a new set of guidelines for best practices in multiple sclerosis (MS) care. The Consortium of Multiple Sclerosis Centers, a network of more than 15,000 clinicians…
Get regular updates to your inbox.
